Inventor

Hua Chee Ooi

Inventor
Mill Creek, WA, US

Overview

11→
Patents
2011–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 11 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07CAcyclic or carbocyclic compounds25%
C07DHeterocyclic compounds25%
PatentTitleYear
10,906,907Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof202110,336,756(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta20199,149,477'5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta'20158,993,583'5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta'20158,980,901'5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta'20158,779,131'6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta'2014RE044638'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'20138,586,597'6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta'2013RE044599'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'20138,207,153'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'20127,932,260'Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2021Patents assigned to ICOS CORP (11)· patent assignee history
2011–2013Based in Kirkland, WA, US· patent location history
2012–2013Patents assigned to FOWLER KERRY W (2)· patent assignee history
2012–2013Patents assigned to HUANG DANWEN (2)· patent assignee history
2012–2013Patents assigned to KESICKI EDWARD A (2)· patent assignee history
2012–2013Patents assigned to OLIVER AMY (2)· patent assignee history
2014–2021Based in Mill Creek, WA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ICOS CORP112011–2021
FOWLER KERRY W22012–2013
HUANG DANWEN22012–2013
KESICKI EDWARD A22012–2013
OLIVER AMY22012–2013
Locations
LocationPatentsSpan
Mill Creek, Washington, US62014–2021
Kirkland, Washington, US52011–2013